The Japanese Ministry of Health, Labor and Welfare has recently established actual performance goals by major policies for fiscal 2006 in order to learn to what extent their achievements will be progressed in figures. The following goals have been set up by each policy field.
For promoting the development of pharmaceuticals and medical devices, and the advancement of the drug industry, the sizes of the respective markets, the number of drugmakers and distributors, and the number of approvals for new drugs and medical devices will be reviewed.
With regard to facilitating the review and approval process for new drugs and medical devices, the ratio of priority reviews to total clearances, the number of approvals and New Drug Applications and the time frame for review of such new products will be assessed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze